Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avalo Therapeutics Inc

4.78
+0.02000.42%
Post-market: 5.010.2300+4.81%18:09 EDT
Volume:93.80K
Turnover:443.78K
Market Cap:51.76M
PE:-0.97
High:4.85
Open:4.78
Low:4.55
Close:4.76
Loading ...
Feb 18, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2022

Major Issues Report

8-K - Current report
Jan 20, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 06, 2022

Major Issues Report

8-K - Current report
Dec 16, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 15, 2021

Major Issues Report

8-K - Current report
Dec 06, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 18, 2021

Major Issues Report

8-K - Current report
Oct 15, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 21, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 17, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 15, 2021

Major Issues Report

8-K - Current report
Sep 09, 2021

Major Issues Report

8-K - Current report
Aug 26, 2021

Major Issues Report

8-K - Current report
Aug 02, 2021

Major Issues Report

8-K - Current report